Boehringer Ingelheim Venture Fund Overview

  • Investor Type
  • Venture Capital
  • Status
  • Active
  • Professionals
  • 12
Professionals
  • Investments
  • 69
  • Portfolio
  • 33
  • Exits
  • 12
Exits

Boehringer Ingelheim Venture Fund General Information

Description

Founded in 2010, Boehringer Ingelheim Venture Fund is the corporate venture capital arm of Boehringer Ingelheim headquartered in Ingelheim am Rhein, Germany. The firm seeks to invest in companies operating in the healthcare sectors.

Contact Information

Year Founded
2010
Investor Status
Actively Seeking New Investments
Primary Investor Type
Corporate Venture Capital
Other Investor Types
Venture Capital
Primary Office
  • Binger Strasse 173
  • 55216 Ingelheim am Rhein
  • Germany
+49 06132 000000

Boehringer Ingelheim Venture Fund Investments (69)

Company Name Deal Date Deal Type Deal Size Industry Company Stage Lead Partner
T3 Pharma 22-Jul-2020 Later Stage VC 000.00 Drug Discovery Generating Revenue 00000 00000000000 00
0000000 0000000000 21-Jul-2020 0000 00000 Drug Discovery Startup 000000000 00000 00.0
0000000 16-Jun-2020 0000 00000 000 Drug Discovery Pre-Clinical Trials 00000000 000000000
0000000 0000000000 16-Jun-2020 00000 00000 000.00 Biotechnology Clinical Trials - General 00000 00000000000 00
000000 06-May-2020 00000 00000 000.00 Enterprise Systems (Healthcare) Generating Revenue 000000 000
00000 000000000000 27-Apr-2020 00000 00000 0000 Drug Discovery Pre-Clinical Trials 00000 000 00.0
000000 02-Apr-2020 0000 00000 0000 Drug Discovery Generating Revenue 000000 000000000 00.0
00000000000 21-Jan-2020 00000 00000 000.00 Drug Discovery Pre-Clinical Trials 00000000 000000000
NBE Therapeutics 10-Jan-2020 Later Stage VC 0000 Drug Discovery Generating Revenue 000000 000000000 00.0
Eyevensys 08-Jan-2020 Later Stage VC 000.00 Biotechnology Generating Revenue 00000 00000000000 00
You’re viewing 10 of 69 investments. Get the full list »
Want detailed data on 2M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Boehringer Ingelheim Venture Fund Exits (12)

Company Name Exit Date Exit Type Exit Size
ArmaGen 20-Apr-2020 Merger/Acquisition
0000 000000000000 15-Jul-2019 000000000000000000 00000
00000 000000000000 01-Jun-2019 000000000000000000 00000
0000000 000000 18-Apr-2019 000 0000
000 000000000000 29-Mar-2019 000000000000000000
0000000000000000 13-Sep-2018 000000000000000000 00000
0000-00 19-Apr-2018 000000000000000000 00000
00000000 26-Oct-2017 000000000000000000 00000
121 Bio 01-May-2017 Out of Business
AMP Therapeutics 03-Nov-2016 Merger/Acquisition
You’re viewing 10 of 12 exits. Get the full list »

Boehringer Ingelheim Venture Fund Investments by Industry, Year, and Region

Investments by Industry

Investments by Year

Investments by Region

PitchBook’s data visualizations quickly surface an investor’s historical investments—showing a breakdown of activity by industry, year and region.

Request a free trial

Boehringer Ingelheim Venture Fund Team (21)

Name Title Deals Funds Boards Office
Frank Kalkbrenner MD Director & Investment Manager 00 0 0 Ingelheim am Rhein, Germany
Ilka Wicke Ph.D Director & Investment Manager 00 0 0 Ingelheim am Rhein, Germany
Martin Heidecker Ph.D BIVF United States office 0 0 0 Cambridge, MA
Johannes Zanzinger Executive 0 0 Ingelheim am Rhein, Germany
Knut Elbers Ph.D Senior Advisor Research Beyond Borders 0 0 Ingelheim am Rhein, Germany
You’re viewing 5 of 21 team members. Get the full list »

Boehringer Ingelheim Venture Fund Co-Investors (123)

Name With Exits Lead Partner Series Industry
High-Tech Gründerfonds 6 0 0 Series chart Industry bar
Life Sciences Partners 0 0 Series chart Industry bar
BioMedPartners 0 0 0 Series chart Industry bar
Idinvest Partners 0 0 0 Series chart Industry bar
Kurma Partners 0 0 0 Series chart Industry bar
You’re viewing 5 of 123 co-investors. Get the full list »